What are the benefits of selective bradycardic agents in the pathophysiology of coronary blood flow and myocardial ischaemia?
According to the research conducted by Heusch G., Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia, selective bradycardic agents are beneficial in improving the coronary blood flow and myocardial ischaemia. This is because bradycardic agents reduce heart rate and thus the oxygen consumption of the heart, which helps to reduce the risk of ischaemia and improve the coronary blood flow.